Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CUPRIC SULFATE

CUPRIC SULFATE

Standard Dose
EQ 0.4MG COPPER/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CUPRIC SULFATE is listed in Drugs@FDA under application 218745 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CUPRIC SULFATE Form and strength INJECTABLE;INJECTION - EQ 0.4MG COPPER/ML Sponsor APOTEX CORP Submission history Latest submission status date: 2024-08-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview CUPRIC SULFATE is listed in Drugs@FDA under application 218745 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CUPRIC SULFATE Form and strength INJECTABLE;INJECTION - EQ 0.4MG COPPER/ML Sponsor APOTEX CORP Submission history Latest submission status date: 2024-08-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.